Risk factors for meningioma in postmenopausal women: Results from the Iowa Women's Health Study

Neuro-Oncology

Volumn 13, Issue 9, 2011, Pages 1011-1019

  Johnson, Derek R ^a   Olson, Janet E ^a   Vierkant, Robert A ^a   Hammack, Julie E ^a   Wang, Alice H ^a   Folsom, Aaron R ^b   Virnig, Beth A ^b   Cerhan, James R ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cohort studies; Epidemiology; Primary brain tumor; Risk factors

Indexed keywords

AGED; ARTICLE; BODY MASS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MENINGIOMA; PHYSICAL ACTIVITY; POSTMENOPAUSE; RISK FACTOR; UTERUS MYOMA; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; BODY MASS INDEX; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IOWA; LIFE STYLE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; POSTMENOPAUSE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; WOMEN'S HEALTH;

EID: 80052699867     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nor081     Document Type: Article

References (35)

1. Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010;99(3):307-314.
2. Umansky F, Shoshan Y, Rosenthal G, Fraifeld S, Spektor S. Radiation-induced meningioma. Neurosurg Focus. 2008;24(5):E7.
3. McKinney PA. Brain tumours: incidence, survival, and aetiology. Journal of neurology, neurosurgery, and psychiatry. 2004;75(Suppl 2:ii):12-17.
4. Benson VS, Pirie K, Green J, Casabonne D, Beral V. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer. 2008;99(1):185-190.
5. Aghi MK, Eskandar EN, Carter BS, Curry WT, Jr, Barker FG, 2nd. Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas. Neurosurgery. 2007;61(4):754-760; discussion 760-751. (Pubitemid 350073272)
6. Korhonen K, Salminen T, Raitanen J, Auvinen A, Isola J, Haapasalo H. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression. J Neurooncol. 2006;80(1):1-7. (Pubitemid 44473255)
7. Cahill DW, Bashirelahi N, Solomon LW, Dalton T, Salcman M, Ducker TB. Estrogen and progesterone receptors in meningiomas. J Neurosurg. 1984;60(5):985-993. (Pubitemid 14134804)
8. Tilzer LL, Plapp FV, Evans JP, Stone D, Alward K. Steroid receptor proteins in human meningiomas. Cancer. 1982;49(4):633-636. (Pubitemid 12165414)
9. Benson VS, Pirie K, Green J, et al. Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int J Cancer. 2010;127(7):1692-1698.
10. Claus EB, Black PM, Bondy ML, et al. Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer. 2007;110(3):471-476. (Pubitemid 47106134)
11. Michaud DS, Gallo V, Schlehofer B, et al. Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2562-2569.
12. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ. Sex steroid hormone exposures and risk for meningioma. J Neurosurg. 2003;99(5):848-853. (Pubitemid 37314920)
13. Mills PK, Preston-Martin S, Annegers JF, Beeson WL, Phillips RL, Fraser GE. Risk factors for tumors of the brain and cranial meninges in Seventh-Day Adventists. Neuroepidemiology. 1989;8(5):266-275. (Pubitemid 19233610)
14. Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: the IowaWomen's Health Study. Arch InternMed. 2000;160(14):2117-2128. (Pubitemid 30482717)
15. Bisgard KM, Folsom AR, Hong CP, Sellers TA. Mortality and cancer rates in nonrespondents to a prospective study of older women: 5-year follow-up. Am J Epidemiol. 1994;139(10):990-1000. (Pubitemid 24156695)
16. Kushi LH, Kaye SA, Folsom AR, Soler JT, Prineas RJ. Accuracy and reliability of self-measurement of body girths. Am J Epidemiol. 1988;128(4):740-748.
17. Kushi LH, Fee RM, Folsom AR, Mink PJ, Anderson KE, Sellers TA. Physical activity and mortality in postmenopausal women. JAMA. 1997;277(16):1287-1292. (Pubitemid 27194352)
18. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. WHO Obesity Technical Report Series 894. Geneva, Switzerland: World Health Organization; 2000.
19. Virnig B, Durham SB, Folsom AR, Cerhan J. Linking the Iowa Women's Health Study cohort to Medicare data: linkage results and application to hip fracture. Am J Epidemiol. 2010;172(3):327-333.
20. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31(8):732-748.
21. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145(1):72-80. (Pubitemid 27009060)
22. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88.
23. Lahmann PH, Hoffmann K, Allen N, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer. 2004;111(5):762-771. (Pubitemid 39062901)
24. McTiernan A, Wu L, Chen C, et al. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring). 2006;14(9):1662-1677. (Pubitemid 46214834)
25. Helseth A, Tretli S. Pre-morbid height and weight as risk factors for development of central nervous system neoplasms. Neuroepidemiology. 1989;8(6):277-282. (Pubitemid 19264520)
26. Tulinius H, SigfussonN, Sigvaldason H, Bjarnadottir K, Tryggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev. 1997;6(11):863-873. (Pubitemid 27481633)
27. Lee M, Wrensch M, Miike R. Dietary and tobacco risk factors for adult onset glioma in the San Francisco Bay Area (California, USA). Cancer Causes Control. 1997;8(1):13-24. (Pubitemid 27092937)
28. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev. 2001;23(2):313-342.
29. OkashaM,Gunnell D, Holly J, DaveySmithG.Childhood growth and adult cancer. Best Pract Res Clin Endocrinol Metab. 2002;16(2):225-241.
30. Heymsfield SB, Gallagher D, Mayer L, Beetsch J, Pietrobelli A. Scaling of human body composition to stature: new insights into body mass index. Am J Clin Nutr. 2007;86(1):82-91. (Pubitemid 47041596)
31. Witelson SF, Beresh H, Kigar DL. Intelligence and brain size in 100 postmortem brains: sex, lateralization and age factors. Brain. 2006;129(Pt 2):386-398. (Pubitemid 43164363)
32. Neilson HK, Friedenreich CM, Brockton NT, Millikan RC. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research. Cancer Epidemiol Biomarkers Prev. 2009;18(1):11-27.
33. Mayer-Davis EJ, D'Agostino R, Jr, Karter AJ, et al. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA. 1998;279(9):669-674. (Pubitemid 28138735)
34. WigertzA, LonnS,Hall P, et al.Reproductive factors and risk ofmeningioma and glioma. Cancer Epidemiol Biomarkers Prev. 2008;17(10):2663-2670.
35. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):571-588. (Pubitemid 351804127)